Clinical trials are becoming more digital, connected, and data-driven. In 2024, clinical trial software is no longer limited to basic study management. Sponsors, CROs, and research organizations are increasingly looking for technology that can simplify trial operations, improve participant engagement, connect data sources, and support faster decision-making.

The shift is happening because clinical research itself is becoming more complex. Trials are collecting information from more sources, involving more stakeholders, and increasingly using decentralized approaches.

According to Towards Healthcare, the global clinical trial management system (CTMS) market was valued at approximately USD 1.3 billion in 2023 and is projected to reach around USD 3.1 billion by 2032, growing at a CAGR of approximately 10.1% from 2024 to 2032. Towards Healthcare

So, what clinical trial software trends should organizations have been watching in 2024?

1. Cloud-Based Clinical Trial Management Is Becoming the New Normal

One of the most important developments is the movement from traditional, locally installed systems toward cloud-based clinical trial software.

Cloud platforms allow sponsors, CROs, investigators, and study teams to access information from different locations without depending on a single physical infrastructure.

This is especially valuable for global clinical trials where teams may be distributed across countries and time zones.

Cloud-based systems can help organizations manage:

• Study planning
• Site management
• Investigator information
• Patient recruitment
• Trial documentation
• Budget and financial management
• Monitoring activities
• Study reporting

The growing adoption of cloud technology is also helping clinical research organizations reduce infrastructure complexity while improving collaboration.

2. Artificial Intelligence Is Entering Clinical Trial Workflows

AI is becoming one of the most closely watched technologies in clinical research.

Rather than replacing clinical research teams, AI-enabled software is increasingly being explored as a tool for handling repetitive work and identifying patterns in large datasets.

Potential applications include:

• Patient recruitment
• Site selection
• Patient matching
• Risk identification
• Trial monitoring
• Data analysis
• Protocol optimization
• Predictive analytics

For sponsors, the attraction is straightforward: better use of data can potentially help research teams make decisions earlier and identify operational problems before they become expensive delays.

As clinical trials generate increasingly large amounts of information, AI and advanced analytics are likely to become increasingly integrated into clinical trial management platforms.

3. Decentralized Clinical Trials Are Influencing Software Design

The traditional clinical trial model depends heavily on participants repeatedly visiting physical research sites.

That model is changing.

Decentralized and hybrid clinical trials allow some trial activities to take place outside conventional research sites through technologies such as:

• Telehealth
• Mobile applications
• Wearable devices
• Remote patient monitoring
• Electronic consent
• Home healthcare visits
• Digital patient-reported outcomes

This shift creates new software requirements.

A CTMS designed only around physical-site workflows may not be sufficient for a study that combines traditional research centers with remote participants.

Modern platforms therefore increasingly need to connect sites, patients, investigators, CROs, and sponsors within a single digital ecosystem.

4. Patient-Centric Technology Is Becoming More Important

Clinical trial software is increasingly being designed around the participant experience.

Recruiting a patient is only the first step. Keeping that participant engaged throughout the study can be equally challenging.

Patient-centric technologies can make participation easier through:

• Digital onboarding
• Electronic informed consent
• Mobile communication
• Appointment reminders
• Remote assessments
• Electronic patient-reported outcomes
• Digital reimbursement
• Virtual visits

The objective is simple: reduce unnecessary friction for participants.

A trial that is easier to participate in may have a better chance of maintaining engagement throughout the study.

5. Electronic Data Capture Is Becoming More Connected

Clinical trials generate data from multiple sources.

These can include:

• Electronic data capture systems
• Electronic health records
• Laboratory systems
• Wearables
• Mobile applications
• Imaging systems
• Patient-reported outcomes
• Remote monitoring platforms

The challenge is no longer simply collecting data.

The bigger challenge is connecting that data and making it usable.

Clinical trial software providers are therefore increasingly focused on integrations and interoperability so that researchers can access a more complete view of the study.

6. Real-Time Trial Visibility Is Becoming a Priority

Clinical trial managers don’t want to discover problems months after they occur.

They increasingly need dashboards and analytics that can provide visibility into trial performance as it happens.

For example, software can help teams monitor:

Patient recruitment → Site performance → Protocol compliance → Data quality → Monitoring → Study milestones

Real-time dashboards can help identify underperforming sites, recruitment bottlenecks, missing data, and operational risks.

This can allow sponsors and CROs to respond earlier rather than waiting for a periodic report.

7. Electronic Informed Consent Is Expanding

Paper-based consent can create administrative challenges, particularly in large or decentralized studies.

Electronic informed consent, or eConsent, allows participants to review and complete consent documentation digitally.

It can also make the process easier to track and manage across multiple research sites.

As clinical trials become more decentralized, eConsent is increasingly becoming an important part of the digital trial technology ecosystem.

8. Integration Is Becoming More Important Than Individual Tools

One of the biggest lessons from the evolution of clinical trial software is that organizations don’t necessarily want dozens of disconnected applications.

They want systems that work together.

A modern clinical research technology environment may need to connect:

CTMS + EDC + eTMF + eConsent + ePRO + randomization + laboratory data + remote monitoring + analytics

When systems operate in isolation, research teams may spend significant time moving information between platforms.

Integrated ecosystems can reduce that burden and give sponsors a more unified view of the study.

9. Data Security and Compliance Remain Critical

More digital data also means greater responsibility.

Clinical trial software handles sensitive research and patient information, so security, access controls, audit trails, data integrity, and regulatory compliance remain fundamental requirements.

As organizations move more clinical operations into cloud environments, vendors need to demonstrate that their platforms can protect information while maintaining appropriate controls for clinical research.

For buyers, technology capabilities should therefore always be evaluated alongside:

• Data security
• Privacy controls
• Audit trails
• Regulatory compliance
• User permissions
• Data integrity
• Backup and recovery

10. Predictive Analytics Is Moving Clinical Trials Toward Proactive Management

Traditional clinical trial management can be reactive.

A problem occurs, and the team responds.

Predictive analytics offers a different approach.

By analyzing historical and real-time information, software can potentially identify patterns associated with:

• Patient dropout
• Site underperformance
• Recruitment delays
• Protocol deviations
• Data-quality problems
• Study delays

This creates an opportunity to move from “What went wrong?” to “What is likely to go wrong next?”

For large, complex clinical trials, that difference can be extremely valuable.

Get smarter healthcare insights with our dedicated Ecosystem Dashboard: https://www.towardshealthcare.com/access-dashboard

What Should Buyers Look for in Clinical Trial Software?

Organizations evaluating clinical trial software in 2024 should look beyond the number of features.

The most important question is whether the platform can support the entire clinical research workflow.

A strong solution should ideally provide:

Scalability

Can the platform support a small clinical study as well as a global Phase III program?

Interoperability

Can it connect with EDC, EHR, laboratory, ePRO, wearable, and other systems?

Automation

Can repetitive administrative activities be automated?

Analytics

Can research teams monitor trial performance through real-time dashboards?

Patient Engagement

Does the platform make participation easier?

Decentralized Trial Support

Can it support remote visits, eConsent, mobile technologies, and remote monitoring?

Security

Does it provide strong access controls, audit trails, and data-protection capabilities?

AI Capabilities

Can AI and predictive analytics support recruitment, monitoring, or operational decision-making?

Why 2024 Was an Important Year for Clinical Trial Software

The clinical trial software market is moving from simple digital recordkeeping toward intelligent clinical research infrastructure.

The combination of cloud computing, AI, decentralized trials, connected devices, patient-centric applications, and analytics is changing how clinical studies are managed.

Towards Healthcare’s market analysis reflects this broader expansion, with the global CTMS market expected to grow significantly through 2032, supported by increasing digitalization of clinical research. Towards Healthcare Clinical Trial Management System Research

The companies that can successfully combine data, automation, analytics, interoperability, and patient engagement will be better positioned as clinical trials become increasingly technology-driven.

Expert Commentary by Payal Rabde – decoding key healthcare trends and industry shifts.

About Us

Pharma Geek is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.

You can place an order or ask any questions, please feel free to contact us at [email protected]

Europe Region – +44 778 256 0738

North America Region – +1 8044 4193 44

APAC Region: +91 9356 9282 04

Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium